Live and recent posts from across the Fediverse tagged #drugpricing, aggregated by home.social.
AHPI Advocates for Fair Drug Pricing Amid Supreme Court Scrutiny, ETHealthworld
New Delhi: The Association of Healthcare Providers of India (AHPI) has called for a balanced approach to pricing…
#NewsBeep #News #Medication #16%margin #AHPI #AU #Australia #cancerdrugsmarkup #Drugpricing #Health #healthcaredeliveryecosystem
https://www.newsbeep.com/au/913603/
AHPI Advocates for Fair Drug Pricing Amid Supreme Court Scrutiny, ETHealthworld
New Delhi: The Association of Healthcare Providers of India (AHPI) has called for a balanced approach to pricing…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #16%margin #AHPI #cancerdrugsmarkup #drugpricing #Health #healthcaredeliveryecosystem
https://www.newsbeep.com/us/868353/
https://www.europesays.com/ie/716655/ AHPI Advocates for Fair Drug Pricing Amid Supreme Court Scrutiny, ETHealthworld #16%Margin #AHPI #CancerDrugsMarkup #DrugPricing #Éire #Health #HealthcareDeliveryEcosystem #IE #Ireland #Medication
AHPI Advocates for Fair Drug Pricing Amid Supreme Court Scrutiny, ETHealthworld
New Delhi: The Association of Healthcare Providers of India (AHPI) has called for a balanced approach to pricing…
#NewsBeep #News #Medication #16%margin #AHPI #cancerdrugsmarkup #Drugpricing #Health #healthcaredeliveryecosystem #UK #UnitedKingdom
https://www.newsbeep.com/uk/789688/
https://www.europesays.com/uk/1232040/ AHPI Advocates for Fair Drug Pricing Amid Supreme Court Scrutiny, ETHealthworld #16%Margin #AHPI #CancerDrugsMarkup #DrugPricing #Health #HealthcareDeliveryEcosystem #Medication #UK #UnitedKingdom
Trump’s final GLOBE rule will save Medicare much less money
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in…
#NewsBeep #News #Headlines #drugpricing #Medicare #STAT+ #World
https://www.newsbeep.com/753867/
https://www.europesays.com/ch/135865/ Novartis Fends Off Antitrust Suit Over Heart Drug’s FDA Status #DrugApprovalProcess #DrugPricing #HealthInsuranceRegulation #monopolization #Novartis #PharmaceuticalPatents #UnfairCompetition(antitrust)
https://www.europesays.com/conflicts/4712/ Flagship, Pentagon, AstraZeneca, GSK: Readout Newsletter #biotech #biotechnology #DrugDevelopment #DrugPrices #DrugPricing #News #Pentagon #PentagonNews #Pharmaceuticals #Policy #research
Flagship, Pentagon, AstraZeneca, GSK: Readout Newsletter
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
#EuropeSays #Britain #Europe #EU #GSK #biotech #Biotechnology #drugdevelopment #Drugprices #Drugpricing #Pharmaceuticals #policy #research
https://www.europesays.com/britain/130090/
https://www.europesays.com/britain/130090/ Flagship, Pentagon, AstraZeneca, GSK: Readout Newsletter #biotech #Biotechnology #DrugDevelopment #DrugPrices #DrugPricing #GSK #Pharmaceuticals #policy #research
Florida Sues Eli Lilly, Sanofi, CVS in Insulin Antitrust Action
The largest makers of insulin and GLP-1s, as well as pharmacy benefit manager giants and rebate companies, were…
#France #FR #Europe #EU #Sanofi #drugpricing #pharmacybenefitmanagement #pharmacycare #stateantitrustlaw
https://www.europesays.com/france/82884/
As the US investigates German drug prices, here’s why Europe should care – POLITICO
Germany was the first EU country to come under specific pressure to raise drug prices, after the U.S.…
#Europe #EU #cars #Drugpricing #EuropeanUnion #Germany #Medicines #patientaccess #Pharma #ResearchandDevelopment #Tariffs #UnitedKingdom #UnitedStates
https://www.europesays.com/europe/144378/
Florida Sues Eli Lilly, Sanofi, CVS in Insulin Antitrust Action
The largest makers of insulin and GLP-1s, as well as pharmacy benefit manager giants and rebate companies, were…
#France #FR #Europe #EU #Sanofi #drugpricing #pharmacybenefitmanagement #pharmacycare #stateantitrustlaw
https://www.europesays.com/france/82872/
https://www.europesays.com/dk/172219/ Trump drug pricing, Medicaid, Novo, GLP-1s: D.C. Diagnosis #DrugDevelopment #DrugPrices #DrugPricing #Medicaid #NovoNordisk #Obesity #Policy #WhiteHouse
https://www.europesays.com/news/73371/ Trump says more drug companies agree to voluntarily lower drug prices #biotechnology #DrugDevelopment #DrugPricing #Headlines #News #Pharmaceuticals #STAT+ #TopStories
Pressure mounts on Europe as Trump deals push pharma to the US – POLITICO
Industry leaders in Europe warn that if the U.S. continues to sign more deals with companies — designed…
#Europe #EU #AdrianvandenHoven #AlexanderNatz #Drugpricing #EU27 #European #Genericsandbiosimilars #Medicines #NathalieMoll #patientaccess #Pharma #UnitedKingdom #UnitedStates
https://www.europesays.com/europe/128211/
Annika Kim Constantino reports that new drug pricing moves may reshape costs for millions of patients. Under a "most favored nation" policy, several pharmaceutical companies are entering voluntary deals to align U.S. medication prices with lower international rates in exchange for certain Medicare exemptions. While the specific impact on out-of-pocket costs is still unfolding, these agreements highlight significant political and industry pressure regarding healthcare affordability. Read more about how these shifts affect patients and industry strategy here: https://www.cnbc.com/2026/08/31/trump-drug-pricing-deals.html #DrugPricing #HealthcareReform
UK approves its second weight-loss pill while EU access lags – POLITICO
However, with the arrival of the first GLP-1 pill Wegovy (semaglutide) from Danish competitor Novo Nordisk — which…
#NewsBeep #News #Medication #CA #Canada #Drugpricing #Germany #Health #Healthtechnologyassessment #Medicines #non-communicablediseases #obesity #Pharma #UnitedKingdom #UnitedStates
https://www.newsbeep.com/ca/853713/
https://www.europesays.com/ch/113745/ AbbVie, Novartis Sue Illinois Over Hospital Drug Pharmacy Law #CivilMonetaryPenalties #DrugPricing #Hospitals #Novartis #PharmacyCare #preemption #SeizureOfProperty #UninsuredPatients
Britain’s pharma policy is a gift to Ireland
Share this article Here’s a fun fact for you: Ireland, a country of just over 5 million people,…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Brexit #ClinicalTrials #corporationtax #Drugpricing #industrialstrategy #INVESTMENT #Ireland #Lifesciences #MHRA #NHS #Pharmaceuticals #Regulation #VPAG
https://www.europesays.com/britain/99466/
https://www.europesays.com/britain/99466/ Britain’s pharma policy is a gift to Ireland #AstraZeneca #Brexit #Britain #ClinicalTrials #CorporationTax #DrugPricing #IndustrialStrategy #INVESTMENT #Ireland #LifeSciences #MHRA #NHS #Pharmaceuticals #Regulation #VPAG
https://www.europesays.com/dk/141667/ Lilly, Novo Get Judge to Toss GLP-1 Compounder’s Antitrust Suit #DrugApprovalProcess #DrugPricing #ExclusiveDealing #NovoNordisk #PharmaceuticalAdvertising #PharmacyCare #Telehealth
https://www.europesays.com/ie/611836/ How rising oil prices can boost the cost of some medicines #DrugPricing #Éire #Health #HIV/AIDS #IE #Ireland #pharmaceuticals #Policy #PublicHealth #STAT+
Iowa audit says PBMs turned accounting moves into millions in profit
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #drugpricing #Health #Medicaid #Pharmaceuticals #STAT+
https://www.newsbeep.com/us/775097/
https://www.europesays.com/ch/95486/ Novartis Loses Appeal to Block Missouri’s Contract Pharmacy Law #DrugPricing #MedicaidEligibility #Novartis #PharmaceuticalPatents #PharmacyCare #preemption #PreliminaryInjunctions #StateHealthCareLegislation
https://www.europesays.com/people/129682/ Trump Taps Chris Klomp as No. 2 Official at RFK Jr.’s HHS #acquisitions #AppointmentsAndPersonnelChanges #Cybersecurity #DonaldTrumpJr #DrugPricing #SocialMedia #Trump
https://www.europesays.com/dk/115364/ Maersk Looks to Ride Vietnam’s Container Wave: Supply Lines #CargoTransportation #CommercialLiens #CustomsDuties #DrugPricing #Exports #ForeignInvestment #InfrastructureFunding #InternationalTradePolicy #Mærsk #NonUSEnvironmentalRegulation #protectionism #TradeAgreements #TradeDeficit #WaterTransportation
FDA approves Colorado’s plan to import cheaper drugs from Canada
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
#Canada #biotechnology #drugpricing #Pharmaceuticals #policy #STAT+
https://www.europesays.com/canada/89854/
FDA approves Colorado’s plan to import cheaper drugs from Canada
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
#Canada #biotechnology #drugpricing #Pharmaceuticals #policy #STAT+
https://www.europesays.com/canada/89438/
https://www.europesays.com/britain/47919/ Senator: Asthma patients suffered as GSK pursued ‘egregious’ price hikes #DrugPricing #GSK #Pharmaceuticals #policy #PublicHealth #STAT+
https://www.europesays.com/dk/85384/ Novo Nordisk Launches Wegovy Subscription Program #DrugCost #DrugCosts #DrugPrice #DrugPricing #GLP1ReceptorAgonists #GlucagonLikePeptide1ReceptorAgonists #HealthCareAccess #HealthServicesAccessibility #insurance #MedicationCosts #MedicationPrice #MedicationPricing #NovoNordisk #Obesity;Obese #PrimaryCare #TelehealthAndTelemedicine;Telemedicine;TelehealthTechnology;RemotePatientMonitoring;Telehealth #WeightLoss #WeightManagement
Drug Giant Eli Lilly Shuns Subsidised Medication Listing, Citing Unfair Price
Eli Lilly refused to list its diabetes drug Mounjaro on Australia's PBS because the government's offered price was too low. This affects 450,000 Australians with Type 2 diabetes.
#EliLilly, #Mounjaro, #DiabetesAustralia, #PBS, #DrugPricing
https://newsletter.tf/eli-lilly-refuses-mounjaro-pbs-listing-australia/
Eli Lilly's decision means Mounjaro won't be subsidised on Australia's PBS. This affects around 450,000 people with Type 2 diabetes who might not get cheaper access to the drug.
#EliLilly, #Mounjaro, #DiabetesAustralia, #PBS, #DrugPricing
https://newsletter.tf/eli-lilly-refuses-mounjaro-pbs-listing-australia/
Toddler Captures Oval Office Spotlight Amid Policy Discussions
A 2-year-old boy's hearing was restored by a Regeneron drug, overshadowing talks on drug costs in the Oval Office on April 23, 2026.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/
A young child's personal medical success story became the main news, even as the government discussed lowering drug prices.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/
Vas Narasimhan, Novartis CEO, warns of serious long-term consequences from President Trump's most favored nation drug pricing policy. The real impact on drugmakers and patients is expected within 18 months as U.S. prices link to lower foreign rates. This policy is set to stay, urging nations to rethink drug pricing strategies. Learn more about its implications. https://www.cnbc.com/2026/04/28/novartis-ceo-stock-earnings-mfn-trump-drug-pricing-policy.html #DrugPricing #Novartis #HealthcarePolicy
Annika Kim Constantino reports: A historic agreement slashes drug prices! Regeneron will offer its FDA-approved hearing-loss gene therapy, Otarmeni, free to eligible U.S. patients. This move, made with President Trump, is a significant step for families needing alternatives to cochlear implants. Learn more about this monumental healthcare development.
https://www.cnbc.com/2026/04/23/regeneron-inks-drug-pricing-deal-with-trump-will-offer-hearing-loss-therapy-for-free.html #DrugPricing #Healthcare #GeneTherapy
340B Drug Pricing Program Under Scrutiny: Examining Program Goals and Real-World Effects
The 340B program helps hospitals get cheaper drugs for poor patients. Learn how it works and why it's being discussed.
#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings
https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/
The 340B program helps hospitals get drugs for low-income patients at lower prices. This program is now being looked at closely by the government.
#340BProgram, #DrugPricing, #HealthcareCosts, #PatientAccess, #HospitalSavings
https://newsletter.tf/340b-drug-program-how-hospitals-get-cheaper-drugs-for-poor-patients/
Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices
Trump’s son is on the board of a prescription drug platform that may benefit from the direct-to-patient medicine sales.
TrumpRx launches with big promises on drug prices, but GoodRx is doing the real work
https://fed.brid.gy/r/https://nerds.xyz/2026/02/trumprx-goodrx/
AOC vs CVS The Hearing That Exposed America’s Healthcare Racket
AOC dismantles CVS Health’s CEO, exposing how corporate consolidation drives up costs, traps patients, and turns healthcare into a profit extraction machine.
#AlexandriaOcasioCortez #corporateConsolidation #CVSHealth #DrugPricing #FTC #healthcareMonopoly #healthcareReform #MedicareForAll #pharmacyBenefitManagers https://wp.me/p1OjMZ-oE8
As Trump Touts 9 New Prescription Drug Deals, Many Call for Systemic Reform
The ongoing battle over Affordable Care Act subsidies has renewed calls for Medicare for All.
Big Pharma Is Making Mexico Sick. Medicine and Supply Shortages Are Rampant.
Mexico manufactures medical devices and medicines, but the majority are exported, leaving residents facing shortages.
A $20 drug in Europe requires a prescription and $800 in the U.S.
https://www.statnews.com/2025/10/31/why-miebo-costs-40-times-more-than-its-european-version/
#HackerNews #drugpricing #prescriptioncosts #healthcare #disparities #Europe #US
https://www.bbc.com/news/articles/cn0k520v4xro
A bad deal for the UK, as drug prices will be forced up.
Pharmaceutical companies hate the bargaining power that the NHS enjoys because of its centralized purchasing system and will be delighted to see the UK government buckle under the US attack.
The zero tariff agreement - even if the the Trump administration keeps its side of the bargain - will benefit corporations rather than patients.
A bad day for the National Health Service and for the UK as a whole. A bad day for other countries too, as the Trump administration will certainly take this as a sign that bullying works when it comes to drug pricing.🙁
##UKPolitics #UKTrade ##DrugPricing #NHS #NationalHealthService #USUKRelations
Eli Lilly is the first health-care company to hit $1T market value, thanks to its weight-loss drugs. The question now: Is this successful innovation, or proof the US drug pricing system is fundamentally broken for patients?
The negotiations were enabled by a law enacted during the Biden administration without any Republican votes.
https://www.nytimes.com/2025/11/25/health/drugs-prices-medicare.html
Prices for Drugs in Medicare’s Second Round of Negotiations
Prices will take effect in 2027.
Cutting prices on drugs with 5-600%... So either americans will be paid way more than they are paying today to get their drugs, or your president does not understand percentages. He has done this before, so it is not a mistake. Trump can't count. How is this accepted?
An attempt to import foreign price controls?
Argument: “By undercutting manufacturers’ ability to set #prices for their products, ‘Most Favored Nation’ could reduce access to novel drugs in America, slow innovation & disrupt the market incentives that deliver the low-priced generic drugs that account for the vast majority of prescriptions in this country (the #USA ).
#healthcare #medication #drugs #pharma
~ The #Trump Admin Is Reviving Its Worst #DrugPricing Policies
Today in The Medium Newsletter, Anna Dorn shares stories by academics influenced by philosopher #HannahArendt: The Radical Politics of Joy by #philosophy professor Roger Berkowitz, and Speaking in Dark Times by sociologist Elisabeth Becker-Topkara.
Other featured stories discuss #DrugPricing in the U.S., #ProstateCancer testing (in the wake of the diagnosis of former president #JoeBiden), and the recent burning of the #NottowayPlantation in Louisiana.
https://blog.medium.com/joy-is-the-radical-belief-that-the-world-is-worthy-of-love-f81faa24e590
Tariffs on Pharmaceuticals May Be the Next Front in Trump’s War on Public Health
Trump and his commerce secretary are threatening to make medications more expensive by slapping tariffs on them.
Swedish drug agency’s new pricing model surprises, concerns patient and pharma groups https://www.euractiv.com/section/health-consumers/news/swedish-drug-agencys-new-pricing-model-surprises-concerns-patient-and-pharma-groups/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Sweden
Dutch trim medicines budget, but cause delayed access to new drugs, says pharma industry https://www.euractiv.com/section/health-consumers/news/dutch-reduced-spend-on-medicines-is-causing-delayed-access-to-new-drugs-says-pharma-industry/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #drugpricing #EUPharmaPackage #Netherlands
Sweden favours compulsory application for medicines reimbursement in any member state requesting it [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/sweden-favours-compulsory-application-for-medicines-reimbursement-in-any-member-state-requesting-it/?utm_source=dlvr.it&utm_medium=mastodon #drugpricing #EUPharmaPackage #healthcare #Sweden
Drug middlemen inflate US prices, squeeze out competition, FTC says - Enlarge / Lina Khan, chair of the Federal Trade Commission (FTC), test... - https://arstechnica.com/?p=2036032 #pharmacybenefitmanagers #expressscripts #cvscaremark #drugpricing #healthcare #science #health #policy #cvs #ftc #pbm
Big Pharma’s fight against drug price reforms takes weird, desperate turn - Enlarge / Stephen Ubl, president and chief executive officer of Pharmac... - https://arstechnica.com/?p=2034140 #medicaredrugpricenegotiations #patentthickets #drugpricing #science #patents #phrma #ip
Drugmaker to testify on why weight-loss drugs cost 15x more in the US - Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordi... - https://arstechnica.com/?p=2032005 #pharmaceuticalindustry #berniesanders #drugpricing #novonordisk #weightloss #science #obesity #ozempic #health #wegovy
European Commission opens infringement procedures against Bulgaria over medicine tenders [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/european-commission-opens-infringement-procedures-against-bulgaria-over-medicine-tenders/?utm_source=dlvr.it&utm_medium=mastodon #Bulgaria #drugpricing #EUPharmaPackage
Breaking: Federal judge rules against two drugmakers' "freedom of speech" argument challenging #Medicare drug price negotiation program
https://www.statnews.com/2024/04/29/federal-judge-rules-against-two-drugmakers-challenging-medicare-drug-price-negotiation-program/ via @STAT